Early Myocardial Function Affects Endocardial Cushion Development in Zebrafish by Bartman, Thomas et al.
Early Myocardial Function
Affects Endocardial Cushion Development
in Zebrafish
Thomas Bartman







6, Didier Y. R. Stainier
1*
1 Department of Biochemistry and Biophysics, University of California, San Francisco, San Francisco, California, United States of America, 2 Department of Pediatrics,
University of California, San Francisco, San Francisco, California, United States of America, 3 Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati,
Ohio, United States of America, 4 Divisions of Neonatology, Pulmonary Biology, and Developmental Biology, Cincinnati Children’s Hospital Medical Center, Cincinnati, Ohio,
United States of America, 5 Whitehead Institute for Biomedical Research, Cambridge, Massachusetts, United States of America, 6 Department of Biochemistry, University of
Iowa College of Medicine, Iowa City, Iowa, United States of America, 7 Division of Pulmonary and Critical Care Medicine, University of California, San Francisco, San Francisco,
California, United States of America
Function of the heart begins long before its formation is complete. Analyses in mouse and zebrafish have shown that
myocardial function is not required for early steps of organogenesis, such as formation of the heart tube or chamber
specification. However, whether myocardial function is required for later steps of cardiac development, such as
endocardial cushion (EC) formation, has not been established. Recent technical advances and approaches have
provided novel inroads toward the study of organogenesis, allowing us to examine the effects of both genetic and
pharmacological perturbations of myocardial function on EC formation in zebrafish. To address whether myocardial
function is required for EC formation, we examined silent heart (sih
 / ) embryos, which lack a heartbeat due to
mutation of cardiac troponin T (tnnt2), and observed that atrioventricular (AV) ECs do not form. Likewise, we
determined that cushion formation is blocked in cardiofunk (cfk
 / ) embryos, which exhibit cardiac dilation and no
early blood flow. In order to further analyze the heart defects in cfk
 /  embryos, we positionally cloned cfk and show
that it encodes a novel sarcomeric actin expressed in the embryonic myocardium. The Cfk
s11 variant exhibits a change
in a universally conserved residue (R177H). We show that in yeast this mutation negatively affects actin
polymerization. Because the lack of cushion formation in sih- and cfk-mutant embryos could be due to reduced
myocardial function and/or lack of blood flow, we approached this question pharmacologically and provide evidence
that reduction in myocardial function is primarily responsible for the defect in cushion development. Our data
demonstrate that early myocardial function is required for later steps of organogenesis and suggest that myocardial
function, not endothelial shear stress, is the major epigenetic factor controlling late heart development. Based on
these observations, we postulate that defects in cardiac morphogenesis may be secondary to mutations affecting early
myocardial function, and that, in humans, mutations affecting embryonic myocardial function may be responsible for
structural congenital heart disease.
Introduction
The genetic programs and developmental processes that
lead to organ formation are still poorly understood. We are
currently witnessing an expansion in research that aims to
identify the genes responsible for the structural development
of organs and their later function. Among the organs of the
body, the heart is unique because it begins to function
mechanically before structural development is complete,
begging the important question of whether myocardial
function is required for the morphogenetic events that occur
after the heart begins beating. One of the late steps of heart
development is the formation of the endocardial cushions
(ECs), which are tissue swellings that develop in characteristic
locations along the anterior–posterior (AP) extent of the
heart tube and contribute to valves and, in four-chambered
hearts, to septae. Because of the clinical signiﬁcance and
prevalence of EC defects in humans (Hoffman 1995), an
understanding of the genetic and epigenetic factors control-
ling cushion and valve formation is critical.
During the process of EC and valve development, speciﬁc
endocardial cells undergo multiple poorly understood spec-
iﬁcation, differentiation, and migration events en route to
becoming functional heart valves. The genes involved in one
substep of this process, epithelial–mesenchymal transforma-
tion (EMT), are gradually being identiﬁed. Analysis of EMT
during cardiac-cushion development has implicated mole-
cules such as Fibronectin, Transferrin, ES-130, hLAMP-1,
TGF-b2, TGF-b3, BMP-2 (reviewed in Nakajima et al. 2000),
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PLoS BIOLOGYAlk-3 (Gaussin et al. 2002), and hyaluronic acid (Camenisch et
al. 2000) as being required for this process. However, many
other molecules are likely to be involved in the complex
process of EMT, and little is known about the events leading
to heart-valve formation that precede or follow EMT,
prompting us to take a forward genetic approach to this
question (Stainier et al. 2002).
To examine the role of epigenetic factors involved in EC
formation, Hove et al. (2003) surgically manipulated zebraﬁsh
embryos and put forth the hypothesis that shear stress on
endocardial cells is required for EC development. In our
study, we use both genetic and pharmacological approaches




 /  Embryos Lack ECs
In zebraﬁsh, an initial step of EC development is the
formation of the endocardial ring, a structure generated by
the clustering of endocardial cells at the atrioventricular (AV)
boundary. This process is easily visualized at 48 h postfer-
tilization (hpf) by examining the endocardial cells expressing
green ﬂuorescent protein (GFP) under the control of the
mouse tie2 promoter (Motoike et al. 2000; Walsh and Stainier
2001) (Figure 1A). We have previously reported the early
cardiac phenotype of silent heart (sih
 / ) embryos, which
establish neither a heartbeat nor blood ﬂow due to mutation
of cardiac troponin T (tnnt2), but do undergo looping morpho-
genesis (Sehnert et al. 2002). We crossed the sih mutation into
the tie2::GFP line and found that although sih
 /  embryos are
otherwise morphologically normal, they fail to form an
endocardial ring at the AV boundary (Figure 1B). Because
sih
 /  embryos do not have a heartbeat and therefore no
blood ﬂow, it is unclear from this observation whether the
defect in EC formation is due to lack of myocardial function
or lack of shear stress on endocardial cells.
cfk
 / Embryos Lack ECs Subsequent to Impaired Function
Through genetic screens (Alexander et al. 1998; Stainier et
al. 2002) we have identiﬁed a new mutant, cardiofunk (cfk), that
fails to accumulate tie2::GFP-positive cells at the AV
boundary by 48 hpf (Figure 1C). We further examined EC
development in cfk
 /  embryos histologically. By 72 hpf, wild-
type embryos have developed AV ECs that are more than one
cell-layer thick (Figure 1D), while cfk
 /  embryos show no
evidence of cushion formation (Figure 1E). Examination by
confocal microscopy further shows that wild-type embryos
have well-developed cushions by 96 hpf (Figure 1F), whereas
cfk
 / embryos still show no evidence of an endocardial ring or
cushion formation (Figure 1G). Thus, EC formation appears
to be defective from an early stage, and not simply delayed, in
cfk
 /  embryos. The lack of EC development in these mutants
leads to toggling of the blood between the atrium and
ventricle and its accumulation inside the heart by 48 hpf
(Figure 1H and 1I; see also Video S1). Interestingly, the
earliest observable phenotype in cfk
 /  embryos is cardiac
dilation, as evidenced by an increase in ventricular end-
diastolic diameter at 36 hpf (Figure 1J and 1K), at which time
cfk
 / embryos have failed to establish a circulation (Video S2).
The cardiac dilation and lack of circulation in cfk
 /  embryos
are nearly fully penetrant phenotypes, while the failure of EC
development occurs in about 50% of cfk
 /  embryos. This
observation raises the possibility that the lack of EC
formation may result secondarily from some other defect,
such as changes in myocardial function or shear stress on
endocardial cells.
AV Boundary Specification Is Not Affected in sih
 /  and
cfk
 /  Embryos
To determine more precisely which step of EC formation is
affected in sih
 /  and cfk
 /  embryos, we examined the
expression of bmp-4, a gene implicated in EC morphogenesis
(Eisenberg and Markwald 1995). In wild-type embryos, bmp-4
is initially expressed throughout the anterior–posterior (AP)
extent of the heart tube before becoming localized to the AV
boundary at 42 hpf (Walsh and Stainier 2001) (Figure 1L). In
sih
 /  and cfk
 /  embryos, bmp-4 expression similarly becomes
restricted to the AV boundary by 42 hpf (Figure 1M) (data not
shown). Therefore, the lack of endocardial ring formation in
sih
 / and cfk
 / embryos does not appear to be due to a defect
in speciﬁcation of the AV boundary, as assessed by bmp-4
expression, nor general arrest of cardiac development. The
wild-typelike restriction of bmp-4 expression in these mutant
embryos contrasts with the situation in jekyll
 /  embryos,
which also lack ECs, but in which bmp-4 expression does not
become restricted to the AV boundary (Walsh and Stainier
2001).
cfk Encodes a Sarcomeric Actin
To understand better the molecular basis for the cfk
phenotypes, we isolated cfk by positional cloning. cfk was
initially localized to a region of LG13 by bulk-segregant
analysis; ﬁne-mapping placed cfk between Z9289 and Z10582
(Shimoda et al. 1999). Analysis of 2,034 meioses allowed us to
perform a chromosomal walk that restricted cfk to bacterial
artiﬁcial chromosome (BAC) zC202M22 (Figure 2A). Follow-
ing the sequencing of zC202M22, a portion of the BAC insert
was assembled as a 52 kb contiguous sequence, and cfk was
genetically localized to this region. Using GenScan (Burge
and Karlin 1997) and BLAST analysis, we identiﬁed four
genes in this 52 kb region: abc-b10, rab4a, actin (zeh0631), and
fv49b10 (Figure 2B). Comparison of this region of the BAC to
fugu and human sequences identiﬁed regions of conserved
synteny on fugu scaffold 2777 (Figure 2C) and human
Chromosome 1q42.13 (Figure 2D) and conﬁrmed our
GenScan analysis. The four zebraﬁsh genes in the critical
interval were analyzed by sequencing from cfk
 /  mutants and
reverse genetic techniques using morpholino antisense
oligonucleotides. Injections of morpholinos against each of
the four coding sequences showed no obvious cardiac
phenotype, indicating that we might not be working with a
loss-of-function mutation or that cfk has overlapping function
with another gene. Subsequently, sequencing of the actin
gene (zeh0631) showed a change of arginine 177 to histidine.
The three embryos recombinant at either end of the 52 kb
region were homozygous at the site of the R177H lesion,
suggesting that we had isolated cfk.
The cardiac dilation caused by the cfk mutation supported
our hypothesis that cfk corresponded to an actin gene.
Analyses of Cfk indicate that it is a sarcomeric actin by
virtue of its homology to zebraﬁsh a-cardiac and a-skeletal
actins and lack of homology to zebraﬁsh cytoplasmic actin, as
well as its conservation of synteny with the human skeletal
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and not a cytoplasmic actin includes the presence of an extra
residue at the N-terminus of Cfk, which is seen in all
sarcomeric actins but no cytoplasmic actins, as well as the
presence of residues that are stereotypic for sarcomeric
actins at all 20 locations where sarcomeric and cytoplasmic
actins have unique amino acids (Khaitlina 2001) (Figure 3A).
Searches of GenBank databases identiﬁed both zebraﬁsh a-
cardiac– and a-skeletal–actin genes that are well represented
in the zebraﬁsh expressed sequence tag (EST) collection and
are related to, but clearly distinct from, cfk (see Figure 3A).
Analysis of multiple actins from several species revealed that
the R177 residue, which is mutated to histidine in the cfk
s11
allele, is universally conserved (Figure 3B). In vitro mutations
at the R177 residue usually affect actin polymerization or
function, although the biochemical effect of an R117H
transition has not been tested.
To determine the expression pattern of cfk, we performed
in situ hybridization with a probe corresponding to its 39
untranslated region (UTR), which is distinct from the 39 UTR
sequences of zebraﬁsh a-cardiac and a-skeletal actins. These
data showed that cfk is expressed in the myocardial but not
endocardial cells of zebraﬁsh embryos from 24 to 48 hpf
(Figure 3C and 3D), suggesting a nonautonomous role in EC
formation. Taken together, the tight linkage between cfk and
this actin gene, the presence of a signiﬁcant genetic lesion in
the actin gene, and the expression proﬁle of the actin gene
indicate that cfk corresponds to the actin gene previously
identiﬁed by the EST zeh0631.
Figure 1. Embryos with Defective Myocardial Function Do Not Form AV ECs
(A–C) Fluorescence micrographs of embryos carrying a tie2::GFP transgene, visualized at 48 hpf. In (A), the endocardial ring is visible as a
collection of GFP-positive cells at the AV boundary in wild-type (wt) embryos (red arrow). In (B), sih
 / embryos fail to form an AV ring at 48 hpf.
In (C), cfk
 /  embryos fail to form an AV ring at 48 hpf.
(D and E) Cushion development remains defective in cfk
 / embryos. In (D), a 5 lm hematoxylin and eosin-stained plastic section shows the initial
stages of cushion development at the AV boundary (red arrows) in a 72 hpf wild-type embryo, with the ECs being two to three cell layers thick at
this stage. In (E), a cfk
 /  embryo at 72 hpf shows dilation of both chambers of a blood-ﬁlled heart with no evidence of cushion formation at the
AV boundary (red arrows).
(F and G) cfk
 / embryos fail to form ECs at late stages. Embryos were visualized at identical magniﬁcation after counter-staining with rhodamine
phalloidin. Red blood cells (RBCs) are seen in the atria of the hearts. In (F), confocal microscopy of a 96 hpf wild-type heart from a tie2::GFP line
shows triangular ECs at the AV boundary (blue arrows). In (G), cfk
 /  embryos at 96 hpf lack cushion formation and clustering of GFP-positive
cells at the AV boundary (blue arrows).
(H) At 72 hpf, wild-type embryos have narrow hearts with forward blood ﬂow through the embryo.
(I) At 72 hpf, cfk
 /  embryos have dilated hearts ﬁlled with blood that regurgitates freely from the ventricle to the atrium.
(J and K) The initial phenotype in cfk
 /  embryos is cardiac dilation at 36 hpf. In (J), wild-type embryos have a narrow ventricle and generate
pulsatile ﬂow at 36 hpf. In (K), cfk
 / embryos have an increased end-diastolic diameter (on average 1.183wild-type, p , 0.01) and do not generate
blood ﬂow at 36 hpf.
(L and M) Increased bmp-4 expression at the AV boundary (red arrow) is observed in wild-type (L) and cfk
 / (M) embryos at 42 hpf in anticipation
of endocardial ring formation.
(N) Orientation of the embryos shown in (L) and (M).
DOI: 10.1371/journal.pbio.0020129.g001
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Previous biochemical studies have revealed a critical role
for R177 in actin polymerization. An R177A yeast variant is
heat sensitive and does not grow in 0.9 M NaCl (Wertman et
al. 1992; Drubin et al. 1993), while an R177D mutation in
chick b-actin leads to severely altered polymerization proper-
ties in vitro (Schuler et al. 2000). These results suggest that a
positive charge at position 177 is important for actin function
in vivo (Wriggers and Schulten 1999). The R177H cfk
s11
mutation represents a less severe change in charge than the
previously mentioned yeast or chick mutations. To assess the
effect of the R177H mutation on actin function, we used site-
directed mutagenesis to generate a haploid yeast strain in
which the R177H mutant actin was the only actin expressed
in the cell. These cells were readily obtained and showed no
signiﬁcant altered morphology or growth characteristics on
normosmolar complete medium at 308C. However, the
R177H mutation produced a severe growth defect, similar
to the R177A mutation, when the cells were incubated in
hyperosmolar complete medium containing 0.9 M NaCl
(Figure 4C).
To determine whether the R177H mutation affected actin
polymerization, we puriﬁed the actin from R177H cells (Cook
et al. 1991) and assessed the extent of polymerization by the
increase in light scattering as a function of time. The mutant
actin exhibited two distinct differences in comparison to a
similarly prepared sample of wild-type yeast actin (Figure
4D). First, the extent of polymerization of a quantity of actin
equal to that of the wild-type sample was signiﬁcantly
decreased as judged by the ﬁnal plateau. Second, there was
a prolonged apparent nucleation phase not seen with wild-
type actin, even at concentrations of mutant actin that
produced more F-actin than the wild-type sample. Samples of
the polymerization solution were negatively stained with
uranyl acetate and examined by electron microscopy to
conﬁrm that the increase in light scattering was caused by F-
actin formation and not merely aggregation (data not shown).
To deﬁne better the apparent difference between R177H and
wild-type actins in regard to the critical concentration
necessary for polymerization, we assessed the extent of
polymerization of different amounts of actin relative to the
amount of total actin using a light-scattering assay. Based on
determinations with two independent preparations of actin,
the critical concentration is 0.3 lM for wild-type actin and 1.9
lM for the mutant actin, conﬁrming that this apparently mild
mutation exerts a drastic effect on actin-ﬁlament stability.
During our work with cfk
s11,w eo b s e r v e dt h a ts o m e
embryos showing the cfk phenotype were cfk
þ/  (Figure 5A),
Figure 2. Positional Cloning of cfk
(A) The locus on zebraﬁsh LG13 containing cfk is shown, with the number of recombinants indicated below each marker. The one recombinant at
the Sp6 end of BAC zC202M22 and the two recombinants at the T7 end of the same BAC deﬁne the critical region.
(B) The ﬁrst 52 kb of zebraﬁsh BAC zC202M22 is shown, including the Sp6 end. One of the two recombinants from the T7 end of the BAC is still
present at a marker at 52 kb, narrowing the critical region to this span. GenScan and BLAST analyses identiﬁed four coding sequences in this
span, including abc-b10 (green), actin (red), a novel EST fv49b10 (black), and rab4a (blue).
(C) Each of the three known genes identiﬁed on BAC zC202M22 has a homologue on scaffold 2777 of Fugu rubripes, in the same orientation
(green, abc-b10; red, actin; blue, rab4a).
(D) The same three genes lie in proximity to each other and in the same order on human Chromosome 1q42.13 (green, abc-b10; red, actin; blue,
rab4a). Units in black are genes, predicted genes, or ESTs, which are unique in this region to that particular organism.
DOI: 10.1371/journal.pbio.0020129.g002
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dominant effect. Indeed, subsequent experiments (Wen and
Rubenstein 2003) demonstrate that the presence of the
mutant actin in a solution of wild-type actin exerts a partially
dominant effect on actin polymerization. The partial dom-
inance of cfk
s11 and the yeast data support a model whereby
substantial copolymerization of Cfk
s11 actin monomers with
wild-type monomers (either Cfk or a-cardiac actin) leads to
unstable ﬁlaments, occasionally giving rise to a phenotype in
heterozygous embryos.
cfk Affects EC Development through Its Effect on
Myocardial Function
Because most cfk
 /  embryos have a dilated heart and lack
blood ﬂow and because subsequently approximately 50% of
these embryos fail to form ECs, we wondered whether these
two phenotypes were causally related or whether lack of EC
formation could occur independently of poor early myocar-
dial function. To address this question, 379 embryos from
multiple cfk clutches were assayed for cardiac dilation and
lack of blood ﬂow at 36 hpf and for lack of endocardial ring
formation at 48 hpf. Embryos that were phenotypically wild-
type at 36 hpf invariably developed endocardial rings over
the next 12 h, whereas all embryos that failed to form
endocardial rings had previously shown a functional pheno-
type at 36 hpf (see Figure 5A). Importantly, the few cfk
 / 
embryos that were phenotypically wild-type at 36 hpf
remained so at 48 hpf. These data strongly suggest that lack
of EC formation occurs secondarily to poor myocardial
function or lack of blood ﬂow at 36 hpf.
Myocardial Function, Not Shear Stress, Is Likely Required
for EC Formation
Because cfk
 /  and sih
 /  embryos each exhibit both a
myocardial phenotype (dilation and silence, respectively) and
fail to generate blood ﬂow, it is impossible to conclusively
state whether EC formation is affected in these embryos
directly as a result of poor myocardial function or indirectly
as a result of the perturbation in blood ﬂow and shear stress
caused by poor myocardial function. Hove et al. (2003)
attempted to address a similar question by inhibiting blood
ﬂow mechanically without affecting myocardial function.
However, other aspects of cardiogenesis were disturbed in
their experiments, leaving open the question of which effects
of their manipulations were primary and which were
secondary. We chose an alternate approach to analyze the
respective roles of myocardial function and blood ﬂow in EC
development by ﬁnding doses of an inhibitor of myoﬁbril
function that would or would not affect blood ﬂow. We
treated tie2::GFP embryos with various concentrations of 2,3-
butanedione monoxime (2,3-BDM), which blocks myoﬁbrillar
ATPase in a dose-dependent manner (Herrmann et al. 1992)
and decreases myocardial force. As the treatment concen-
tration of 2,3-BDM increased, the percentage of embryos that
formed endocardial rings at 48 hpf decreased (Figure 5B).
Importantly, blood ﬂow was abolished in all embryos treated
with 2,3-BDM at 6 mM or higher, yet 58% of them (n = 74)
formed an endocardial ring, indicating that blood ﬂow is not
required for the initial steps of cushion formation. When
myoﬁbril function was further decreased by treatment with
10 mM 2,3-BDM, the percentage of embryos with an
Figure 3. Sequence and Expression Anal-
ysis of cfk
(A) cfk encodes a sarcomeric actin highly
homologous to zebraﬁsh a-cardiac and
a-skeletal actins. Cfk differs from zebra-
ﬁsh a-cardiac actin at six residues and
from zebraﬁsh a-skeletal actin at four
residues, but from zebraﬁsh b-actin at 28
residues. Residues in red are those that
differ from Cfk. Dots above the sequence
indicate residues that universally distin-
guish sarcomeric from cytoplasmic ac-
tins. The arrow at R177 indicates the
location of histidine in Cfk
s11.
(B) The arginine at position 177 is
universally conserved in all actin pro-
teins examined.
(C and D) cfk is expressed in the
myocardium during development. In
(C), whole-mount in situ hybridization
on a cmlc2::GFP embryo at 36 hpf shows
that cfk is expressed throughout the AP
extent of the heart tube. Blue staining
indicates areas of cfk expression; green is
the region of cmlc2 expression. The red
arrow indicates the heart tube. In (D), a
plastic section of stained embryo shows
cfk expression in the myocardium of the
heart (blue arrow), but not in the
endocardial cells (red arrow). From the
onset of its expression in the heart
region (around the 16-somite stage), cfk
does not appear to be expressed in
endothelial and endocardial cells. Weak
cfk expression is also seen in the somites
(data not shown).
DOI: 10.1371/journal.pbio.0020129.g003
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anesthetic tricaine conﬁrmed the observation that ECs may
form in the absence of blood ﬂow and that the likelihood of
forming cushions is inversely proportional to the concen-
tration of tricaine (data not shown). In summary, the results
from the 2,3-BDM and tricaine treatments suggest that it is
poor myocardial function, and not lack of blood ﬂow, which
is primarily responsible for the loss of EC formation in cfk
 / 
and sih
 /  embryos.
Discussion
The hearts of sih
 /  embryos fail to beat yet undergo
looping morphogenesis and AV boundary speciﬁcation. The
speciﬁc absence of EC formation in these embryos clearly
demonstrates that myocardial function is required for EC
formation. Precisely how myocardial function is required for
EC formation is unclear. Prior work has demonstrated a
requirement for AV boundary myocardium in the formation
of ECs, and several signaling molecules emanating from the
myocardium at the AV boundary have been identiﬁed
(reviewed in Eisenberg and Markwald 1995). Although we
have shown that the expression of bmp-4 is not affected by
myocardial function defects, it is possible that myocardial
function is somehow required for another aspect of this
signaling event.
Hove et al. (2003) recently argued for the importance of
intracardiac hemodynamics as a key epigenetic factor
affecting embryonic cardiogenesis. In their experiments,
blood ﬂow into the heart was eliminated by surgical place-
ment of a bead at the inﬂow tract. One of the resulting
phenotypes in these embryos was lack of EC formation,
leading them to hypothesize that a reduction in shear stress
on endocardial cells caused this phenotype. However, it is
possible that the lack of EC formation observed by Hove et al.
(2003) in surgically manipulated embryos was secondary to
either the lack of looping observed in these same embryos, an
effect on myocardial function by the surgical manipulations,
or a more general arrest of cardiac development. In contrast,
sih
 /  embryos undergo looping morphogenesis, making them
perhaps a more appropriate model to analyze, and these
embryos also lack ECs. Therefore, myocardial function and/or
blood ﬂow appear to play a role in EC development. Data
from 2,3-BDM and tricaine treatments, in which many
embryos without blood ﬂow still formed ECs, suggest that
endocardial shear stress may not be key to EC morphogenesis.
In mouse, a number of studies indicate that mutation of a
single gene, including tbx5 (Bruneau et al. 2001), nkx2.5
(Schott et al. 1998; Biben et al. 2000), and has2 (Camenisch et
al. 2000), affects both myocardial function and cardiac
morphogenesis. These mutations have been thought to affect
cardiac structural development and function in parallel
pathways or in a causal pathway with the abnormal structure
of the hearts leading to abnormal function. Based on our
analyses of cfk, we would like to propose an alternative
interpretation, namely that some of these mutations may
Figure 4. An Arginine to Histidine Change
at Position 177 of Cfk Alters the Location of
Positive Charges in the Nucleotide Binding
Cleft of Actin
(A) The position of R177 (red) in the
structure of the yeast-actin monomer.
The bound ATP is shown in green. The
structure shown is based on a crystal
structure of actin (PDB:1YAG).
(B) Magniﬁcation of the cleft region
showing the hydrogen bonding (green
dashed lines) involving R177, which will
be disrupted in H177.
(C) The R177H mutation restricts yeast
growth under hyperosmolar stress. Wild-
type (wt) and mutant cells were grown to
a density of 3 3 10
6 per milliliter, and
aliquots were plated either on YPD or
YPD plus 0.9 M NaCl at different
dilutions of the culture. The cells were
then incubated at 308C for 72 h. The
normosmolar and hyperosmolar experi-
ments were done at different times.
(D) Puriﬁed R177H actin has a higher
critical concentration of polymerization
and a delayed nucleation phase. Wild-
type or mutant actin was puriﬁed from
yeast cultures and polymerization mea-
sured by light diffraction. Symbols and
abbreviations: circles, 5 lM wild-type
actin; triangles, 5 lM R177H actin;
diamonds, 7.5 lM R177H actin; squares,
10 lM R177H actin; ATP, adenine
triphosphate; wt, wild-type.
DOI: 10.1371/journal.pbio.0020129.g004
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disrupts subsequent steps of heart morphogenesis. This
model is supported by studies of the ncx1 null mouse, in
which the heartbeat is eliminated and the EMT associated
with EC development appears to be defective (Koushik et al.
2001). The ncx1studies, together with ours, indicates that EC
development may be particularly sensitive to perturbations in
myocardial function. However, because of the difﬁculty in
completely unlinking heart function and blood ﬂow, further
studies will be required to elucidate the exact contributions
of myocardial function and endothelial shear stress on
cushion and valve morphogenesis.
Our data show that mutations in two different sarcomeric
genes lead to EC defects in zebraﬁsh. Similar mutations
affecting myocardial function may thus cause EC defects in
humans. While most infants born with EC defects exhibit
relatively normal myocardial function, actin-gene expression
is known to undergo signiﬁcant changes during development
(Cox and Buckingham 1992). Thus, a mutation in an actin
gene expressed in the heart during embryogenesis, when
control of actin-gene expression appears to be less speciﬁc
than in the mature animal, could lead to an EC phenotype
without apparent effects on myocardial function at birth. As
shown by the cfk mutant, it is possible that genetic lesions in
actin genes expressed only transiently in myocardial cells
could cause embryonic cardiovascular phenotypes, partic-
ularly if those lesions act in a dominant manner. Therefore, as
we seek to identify the genes responsible for human cardiac
malformations, those primarily involved in myocardial
function should also be considered.
Materials and Methods
Zebraﬁsh. Zebraﬁsh were maintained and staged as described
(Westerﬁeld 2000). We used the sih
tc300b allele (Chen et al. 1996) and
the cfk
s11 allele identiﬁed in a screen in our laboratory (Alexander et
al. 1998). Animal protocols were approved by the Committee on
Animal Research of the University of California, San Francisco (San
Francisco, California, United States).
In situ hybridization. We carried out whole-mount in situ hybrid-
ization as described elsewhere (Alexander et al. 1998). We used
antisense RNA probes to bmp-4 (Nikaido et al. 1997) and the 39 UTR
of cfk. Visualization of GFP-positive cells after in situ hybridization
was performed by treating embryos with a rabbit anti-GFP-IgG
followed by a ﬂuoresceinated mouse anti-rabbit-IgG.
Morpholino antisense ‘‘knock-down.’’ We designed morpholino
oligonucleotides (Gene Tools, Philomath, Oregon, United States) to
bind to the initiation codon and ﬂanking sequences of the following
zebraﬁsh genes: sih (Sehnert et al. 2002), rab4a (59-GTCTCTGACAT-
GACTGACGCTGCGT-39), abc-b10 (59-TCATTCGCAACATTGTCC-
CATACAT-39), fv49b10.y1 (59-CCGACCTAATTCGCTTGGT-
CACCAT-39), and cfk (59-CATCTTGATGTATTCTTTCTCTGCT-39).
The morpholinos were injected at 4 ng and 8 ng into tie2::GFP
embryos at the one-cell stage and examined at 24 to 72 hpf for
myocardial function and EC phenotypes. Morpholinos against abc-
b10, rab4a, and fv49b10.y1 did not affect myocardial function or EC
formation. The cfk morpholino caused no phenotype, an expected
result given the ability of actin genes to compensate for each other
when down-regulated (Kumar et al. 1997; Crawford et al. 2002) and
the redundancy of cfk with a-cardiac actin.
Genetic mapping. We genotyped diploid mutant embryos from a
cfk
s11-AB/SJD hybrid strain using SSLP with various CA repeat
markers and SSCP with various ESTs. SSCP was performed by
denaturing PCR products at 958C for 10 min in 0.7 mM EDTA and 36
mM NaOH and placing on ice before loading on nondenaturing
acrylamide gels. BAC library ﬁlters for the CHORI-211 (zC) library
were obtained from P. de Jong at BACPAC (Oakland, California,
United States). Linkage of the R177H mutation to the cfk
s11 allele
(through genotyping of mutant embryos) was accomplished by
performing PCR across the mutation (forward primer = 59-
ATCGTGCTGGACTCTGGTG-39 and reverse primer = 59-GAAA-
GAATAACCGCGCTCAG-39) and digesting with NsiI, which cuts only
the H177 allele. Synteny analysis was performed through http://
genome.jgi-psf.org/fugu3/fugu3.home.html (fugu) and http://
genome.ucsc.edu (human).
Mutation detection. We used a pool of 25 cfk
s11 mutant embryos to
extract mRNA (Trizol, GIBCO–BRL, Gaithersburg, Maryland, United
States) and synthesize cDNA (SuperScript First Strand, Invitrogen,
Carlsbad, California, United States). PCR was then performed from
the 59 UTR to 39 UTR and multiple clones sequenced. To conﬁrm that
the amino acid change we saw was a mutation and not a poly-
morphism in the strain used for mutagenesis, we examined the DNA
of four F1 females from the screen (Alexander et al. 1998) in which cfk
Figure 5. Lack of EC Formation Is Secondary to Defective Myocardial Function
(A) Embryos were observed for defective myocardial function and lack of blood ﬂow at 36 hpf and lack of endocardial ring formation at 48 hpf.
Approximately half of the embryos with defective myocardial function at 36 hpf did not develop endocardial rings. All embryos with a lack of
endocardial rings previously demonstrated a myocardial function phenotype at 36 hpf. Further analyses including the genotyping of a subset of
embryos showed that a small percentage of cfk
 /  embryos were unaffected at 36 hpf and that they subsequently developed ECs.
(B) Embryos treated from 24 to 48 hpf with 2,3-BDM to decrease myocardial force failed to develop endocardial rings in a dose-dependent
manner. Loss of ring formation was not linked to loss of blood ﬂow—14% of embryos treated at 4 mM 2,3-BDM did not form rings despite the
presence of blood ﬂow, and 58% of embryos treated at 6 mM did form rings despite the absence of blood ﬂow.
(C) Example of an embryo treated with 10 mM 2,3-BDM that failed to develop an endocardial ring at the AV boundary (red arrow).
DOI: 10.1371/journal.pbio.0020129.g005
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mosaic for the mutation. This female, but not her three sisters, was
indeed mosaic for the mutation (data not shown).
Pharmacological treatment of embryos. Clutches of dechorionated
embryos were placed in 2,3-BDM (Sigma B-0753, Sigma–Aldrich, St.
Louis, Missouri, United States) at 24 hpf at concentrations between 2
and 20 mM. This concentration range has been shown to affect
myoﬁbrillar ATPase in a dose-dependent manner, with 25% of
activity remaining at 10 mM (Herrmann et al. 1992). 2,3-BDM had a
rapid onset of action—at 2 and 4 mM, the embryos had visibly
weakened heartbeats within minutes, and at 6 mM or greater the
myocardial force was weakened enough to eliminate blood ﬂow
almost immediately. During the next 24 h, the embryos were
examined periodically to ensure that the pharmacological effect
remained constant over time. At 48 hpf the presence or absence of
the endocardial ring was assayed. For tricaine treatment, dechorio-
nated embryos were placed in a solution of 0.4 mg/ml ethyl 3-
aminobenzoate methanesulfonate salt (Sigma A-5040, MS-222, 886–
86-2) from 24 to 48 hpf and assayed for myocardial function during
that time and for EC formation at 48 to 54 hpf.
Yeast-actin biochemistry. Site-directed mutagenesis of the yeast-
actin coding sequence in a centromeric plasmid and construction of
haploid cells producing only the mutant actin were carried out as
described previously (Cook et al. 1992). Wild-type and mutant actins
were puriﬁed using a DNase I agarose/DEAE-cellulose-based proce-
dure as described previously (Cook et al. 1991). G-actin was stored at
48C in G-buffer (10 mM Tris–HCl [pH 7.5], containing 0.2 mM ATP,
0.2 mM CaCl2, and 0.1 mM DTT) and used within 2 d. Actin
polymerization was induced by the addition of MgCl2 and KCl to ﬁnal
concentrations of 2 mM and 50 mM, respectively, and polymerization
was assessed by the increase in light scattering as a function of time at
258C in a 120 ll volume in a thermostatted cuvette using a SPEX
Fluorolog 3 ﬂuorimeter with excitation and emission wavelengths set
at 360 nm.
Supporting Information
Video S1. Phenotype of Wild-Type and cfk
 /  Embryos at 72 hpf
Wild-type hearts propel blood through the vasculature, whereas cfk
 / 
hearts have complete regurgitation of blood from the ventricle to the
atrium and therefore no forward blood ﬂow.
Found at DOI: 10.1371/journal.pbio.0020129.sv001 (2.91 MB MOV).
Video S2. Phenotype of Wild-Type and cfk
 /  Embryos at 36 hpf
Wild-type embryos have a narrow, strongly contracting heart and
generate effective blood ﬂow. cfk
 /  embryos (two different embryos
shown) have dilated hearts with weak contractions and are not
capable of generating circulation.
Found at DOI: 10.1371/journal.pbio.0020129.sv002 (2.9 MB MOV).
Accession Numbers The GenBank (http://www.ncbi.nlm.nih.gov/
Genbank/index.html) accession numbers discussed in this paper are
for cfk (AY222742), zebraﬁsh a-cardiac actin (AF116824), zebraﬁsh a-
skeletal actin (AF180887), and zebraﬁsh cytoplasmic actin
(AF057040).
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